Ocala Oncology Center Pl Dba Florida Cancer Affiliates Ocala

Ocala, Florida 34474

2 studies enrolling now · 4 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer, NSCLC, Neoplasm Metastasis, Non-small Cell Lung Cancer

Studies at this site

• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer — Recruiting now
• A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer — Recruiting now
• A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer — Stopped early
• Combination Margetuximab, Retifanlimab, Tebotelimab, and Chemotherapy Phase 2/3 Trial in HER2+ Gastric/GEJ Cancer — Completed